MJ

Mohammad Javed

Active Director Director DIN 09674682
DIN 09674682 First appointment Jul 2022 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Mohammad Javed

Data last updated:

Mohammad Javed is a Director at Triaim Pharma Private Limited (since 2022). The company operates in Business Services. Triaim Pharma Private Limited reported revenue of ₹93 Lakh (FY 2024).

DIN 09674682
Primary Designation Director
Industry Business Services
First Appointment 01 Jul 2022
Oldest Company Age 9 yrs
Largest company Triaim Pharma Private Limited · ₹93 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Triaim Pharma Private Limited U74999MP2017PTC043768
Director01 Jul 20222017₹93 Lakh (FY 2024)Active

Board colleagues of Mohammad Javed

Directorship timeline

Open interactive timeline →
Triaim Pharma Private Limited
Premium access

Shareholding and investment profile for Mohammad Javed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Javed

Mohammad Javed currently holds 1 directorship: Triaim Pharma Private Limited (Director, since 01 Jul 2022, revenue ₹93 Lakh (FY 2024)).

Mohammad Javed was first appointed on 01 Jul 2022 as Director at Triaim Pharma Private Limited.

The current boards of Mohammad Javed's companies include Bhavna Sakwar (Triaim Pharma Private Limited), Manisha Shrivas (Triaim Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available